Alphatec Spine v. NuVasive CA4/1

CourtCalifornia Court of Appeal
DecidedApril 23, 2026
DocketD084368
StatusUnpublished

This text of Alphatec Spine v. NuVasive CA4/1 (Alphatec Spine v. NuVasive CA4/1) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Alphatec Spine v. NuVasive CA4/1, (Cal. Ct. App. 2026).

Opinion

Filed 4/23/26 Alphatec Spine v. NuVasive CA4/1 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

COURT OF APPEAL, FOURTH APPELLATE DISTRICT

DIVISION ONE

STATE OF CALIFORNIA

ALPHATEC SPINE INC., D084368

Plaintiff and Respondent,

v. (Super. Ct. No. 37-2017- 00038583-CU-BC-CTL) NUVASIVE INC.,

Defendant and Appellant.

APPEALS from an amended judgment and order of the Superior Court of San Diego County, Richard S. Whitney, Judge. Affirmed. Procopio, Cory, Hargreaves & Savitch, Kendra J. Hall, and Jeff S. Hood for Defendant and Appellant. Winston & Strawn, Nimalka Wickramasekera, Brian Nisbet, Libby Deshaies, Michael Meneghini, and Michael J. Woodrum for Plaintiff and Respondent.

NuVasive Inc. (NuVasive) appeals from the trial court’s amended judgment and a postjudgment order denying its motion for judgment notwithstanding the verdict (JNOV). NuVasive argues the court erred in concluding its posttrial motions for JNOV and new trial were untimely. Additionally, it asserts the jury’s special verdict finding that Alphatec Spine Inc. (Alphatec) intentionally interfered with the contractual relationship between Kenneth Kormanis, a sales representative, and inoSpine, LLC (inoSpine), an exclusive distributor of NuVasive products in North Carolina, is inconsistent with its verdict that Alphatec did not violate North Carolina’s Unfair and Deceptive Trade Practices Act (NCUDTPA) by tortiously interfering with the contracts Michael Jones and Kormanis had with inoSpine. In its view, the court should have required the jury to clarify its verdict when NuVasive raised the issue at trial. It contends the court further erred by not granting JNOV in its favor on its claim under the NCUDTPA based on the jury’s finding on a separate cause of action that Alphatec tortiously interfered with Kormanis’s contract. Alphatec responds that the court’s order should be affirmed because the posttrial motions were not timely filed and the court did not otherwise err. We conclude NuVasive’s posttrial motions were timely, but the verdicts were not inconsistent. We further conclude that JNOV could not lawfully be granted on the NCUDTPA claim based on the jury’s verdict on the separate intentional interference claim. Accordingly, we affirm the amended judgment and order denying JNOV.

FACTUAL AND PROCEDURAL BACKGROUND1 A. Factual Background Alphatec and NuVasive are competitors in the medical device market. Both offer surgical tools and procedures used to treat spinal disease. NuVasive hires distributors and direct salespeople who exclusively represent

1 The background section is limited to only those facts relevant to the issues on appeal.

2 NuVasive and are essentially given a franchise to cover the doctors and hospitals in certain geographical areas. Because its sales representatives form relationships with surgeons in their respective territories, NuVasive’s contracts with its distributors and representatives prohibit them from promoting competitors’ products. The contracts also include post-termination restrictions preventing former distributors from selling competing products and soliciting former NuVasive customers. Kormanis and Jones worked as sales representatives for inoSpine, an exclusive distributor of NuVasive products in North Carolina. Each entered into agreements with inoSpine, governed by North Carolina law, with NuVasive as a third-party beneficiary. Kormanis worked with Dr. Benjamin Ditty, among others, and Jones provided products and guidance to Dr. William Hunter. Patrick Miles had served as NuVasive’s president, chief operating officer, and vice chairman until becoming Alphatec’s executive chairman in 2017. That same year, Greg Rhinehart, Alphatec’s vice president of sales for the eastern United States, contacted Kormanis and Jones and recruited them to join Alphatec. After Kormanis received his Alphatec contract but while he was still working for inoSpine, Rhinehart asked Kormanis to provide Dr. Ditty’s contact information, noting that Dr. Ditty would be meeting Miles, Alphatec’s then-executive chairman. Kormanis obliged and also shared sales revenue data from Dr. Ditty’s surgeries. After Kormanis and Jones started at Alphatec in March 2018, Alphatec swapped their NuVasive territories. Dr. Ditty began transitioning his cases over to Alphatec the same month. He confirmed that he stopped using NuVasive products because Kormanis would no longer be providing coverage for NuVasive cases.

3 NuVasive also presented evidence of alleged interference with its relationships with 11 other physicians in several other states. B. Procedural Background Alphatec and Miles filed a complaint against NuVasive in the San Diego Superior Court. NuVasive then filed this lawsuit against Alphatec. Its first amended complaint alleged causes of action for (1) unfair competition; (2) intentional interference with contractual relations with distributors in multiple states, including distributors in Florida and North

Carolina that collectively serviced nine physicians2; (3) intentional interference with prospective economic advantage; (4) negligent interference with prospective economic advantage; (5) Deceptive and Unfair Trade Practices (Fla. Stat. § 501.201 et seq.); and (6) Deceptive and Unfair Trade Practices (N.C. Gen. Stat. § 75.1.1). Alphatec and Miles’s lawsuit was ultimately dismissed, and only NuVasive’s lawsuit against Alphatec proceeded to trial. At the conclusion of the 10-week trial, NuVasive asked the jury to award it a total of $32 million dollars in damages for all its claims. The jury returned the special verdict after deliberating for a little over two days. Noting that the jury had written “Not applicable” (NA) instead of checking “Yes” or “No” in certain places, the court sent the jury back out with a new verdict form and instructions to “get rid of the NAs.” When the jury returned with a revised special verdict, the court read it aloud. On the intentional interference with contractual relations claim, the jury concluded Alphatec’s conduct was only a substantial factor in causing

2 At trial, NuVasive also claimed interference with a Massachusetts distributor that provided NuVasive products and services to three additional physicians. 4 harm to NuVasive as to Dr. Ditty. It found NuVasive’s damages to be $812,002 as to Dr. Ditty. It did not award damages as to any of the other 11 physicians. Likewise, on the intentional interference with prospective economic advantage claim, the jury concluded Alphatec only engaged in wrongful conduct as to Kormanis. It found no wrongful conduct as to the Florida or Massachusetts distributors or as to Jones in North Carolina. And, although it found the intentional interference with prospective economic advantage affecting Kormanis was a substantial factor in causing harm to NuVasive via Dr. Ditty, it did not award any damages on

this claim.3 Finally, the jury rejected the claims that Alphatec violated the Florida Deceptive and Unfair Trade Practices Act and the NCUDTPA and concluded punitive damages were not warranted. NuVasive then asked that the jury be polled. On Special Verdict Form

Question No. 6,4 the vote on damages for the intentional interference with

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Universal Sales Corp. v. California Press Manufacturing Co.
128 P.2d 665 (California Supreme Court, 1942)
Gibson v. Southern Pacific Co.
290 P.2d 347 (California Court of Appeal, 1955)
Dalton v. Camp
548 S.E.2d 704 (Supreme Court of North Carolina, 2001)
Ellis v. Northern Star Co.
388 S.E.2d 127 (Supreme Court of North Carolina, 1990)
Giles v. Happely
267 P.2d 1051 (California Court of Appeal, 1954)
Ramirez v. Moran
201 Cal. App. 3d 431 (California Court of Appeal, 1988)
Tri-County Elevator Co. v. Superior Court
135 Cal. App. 3d 271 (California Court of Appeal, 1982)
National Advertising Co. v. City of Rohnert Park
160 Cal. App. 3d 614 (California Court of Appeal, 1984)
Mendoza v. Club Car, Inc.
96 Cal. Rptr. 2d 605 (California Court of Appeal, 2000)
Magic Kitchen LLC v. Good Things International, Ltd.
63 Cal. Rptr. 3d 713 (California Court of Appeal, 2007)
Shaw v. Hughes Aircraft Co.
100 Cal. Rptr. 2d 446 (California Court of Appeal, 2000)
City of San Diego v. D.R. Horton San Diego Holding Co.
24 Cal. Rptr. 3d 338 (California Court of Appeal, 2005)
Stillwell v. the Salvation Army
167 Cal. App. 4th 360 (California Court of Appeal, 2008)
Zagami, Inc. v. James A. Crone, Inc.
74 Cal. Rptr. 3d 235 (California Court of Appeal, 2008)
MIZEL v. City of Santa Monica
113 Cal. Rptr. 2d 649 (California Court of Appeal, 2001)
Dodge v. Superior Court
91 Cal. Rptr. 2d 758 (California Court of Appeal, 2000)
Singh v. Southland Stone, U.S.A., Inc.
186 Cal. App. 4th 338 (California Court of Appeal, 2010)
Alan v. American Honda Motor Co., Inc.
152 P.3d 1109 (California Supreme Court, 2007)
Palmer v. GTE California, Inc.
70 P.3d 1067 (California Supreme Court, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
Alphatec Spine v. NuVasive CA4/1, Counsel Stack Legal Research, https://law.counselstack.com/opinion/alphatec-spine-v-nuvasive-ca41-calctapp-2026.